文献速递肺栓塞与肺血管病

安非他酮吸入致弥漫性肺泡出血一例

Diffuse Alveolar Hemorrhage Due to Bupropion Inhalation.
PubMed 文献 · Chest · 2024-01-01

本文报告一例因吸入安非他酮(一种去甲肾上腺素-多巴胺再摄取抑制剂)导致弥漫性肺泡出血(DAH)的病例,为作者所知的首例报道,经全身性类固醇治疗成功。该病例为DAH的已知病理原因增添了新药物,并提示在适当临床背景下应考虑安非他酮作为DAH的病因。

要点

  • 吸入安非他酮可导致弥漫性肺泡出血(DAH)。
  • 该病例经全身性类固醇治疗成功。
  • 在DAH的适当临床背景下应询问安非他酮吸入史。

核心结论

  • 吸入安非他酮是弥漫性肺泡出血(DAH)的一种新病因,经全身性类固醇治疗成功。

研究设计与样本

  • 病例报告(单例)。

主要发现

  • 患者因吸入安非他酮发生弥漫性肺泡出血(DAH)。
  • 该病例经全身性类固醇治疗成功。

临床怎么用

  • 在DAH的适当临床背景下,应将安非他酮吸入视为可能的病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diffuse alveolar hemorrhage (DAH) is a form of hemoptysis caused by disruption of the alveolar-capillary basement membrane causing alveolar bleeding. Inhalation of cocaine and other sympathomimetic agents are described as one of many pathologic causes. We describe what is to the author's knowledge the first reported case of DAH caused by inhalation of bupropion, a norepinephrine-dopamine reuptake inhibitor, which was successfully treated with systemic steroids. This case adds a novel agent to the known pathologic causes of DAH and introduces a novel form of bupropion toxicity, which should be considered as a cause in cases of DAH in the appropriate clinical context. The case also highlights the potential for further research into the pathologic interactions of bupropion at the alveolar basement membrane.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Kuschner Z, Gearges C, Asghar Z, et al. Diffuse Alveolar Hemorrhage Due to Bupropion Inhalation. Chest. 2024. PMID: 39521546. doi:10.1016/j.chest.2024.05.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。